Vertex Pharmaceuticals (VRTX) Convertible Debt (2010 - 2013)
Vertex Pharmaceuticals (VRTX) posted Convertible Debt of $400.0 million for Q1 2013, little changed on a QoQ basis from $400.0 million in Q4 2012, and little changed year-over-year from $400.0 million in Q1 2012.
Powered by 
Analysis
Vertex Pharmaceuticals (VRTX) Convertible Debt (2010 - 2013) Analysis & Trends
Vertex Pharmaceuticals has reported Convertible Debt for 4 years, with the latest figure at $400.0 million in Q1 2013.
- On a quarterly basis, Convertible Debt changed 0.0% year-over-year to $400.0 million in Q1 2013; TTM through Mar 2013 was $400.0 million, a 0.0% change from a year earlier, with the FY2012 full-year figure at $400.0 million, changed 0.0% from the prior year.
- Convertible Debt was $400.0 million for Q1 2013 at Vertex Pharmaceuticals, roughly flat from $400.0 million in the prior quarter.
- The five-year high for Convertible Debt was $400.0 million in Q3 2010, with the low at $32.1 million in Q1 2010.
- Average Convertible Debt over 4 years is $366.6 million, with a median of $400.0 million recorded in 2010.
- The largest YoY upside for Convertible Debt was 1146.11% in 2011 against a maximum downside of 0.0% in 2011.
- Over 4 years, Convertible Debt stood at $400.0 million in 2010, then changed by 0.0% to $400.0 million in 2011, then changed by 0.0% to $400.0 million in 2012, then changed by 0.0% to $400.0 million in 2013.
- The last three Convertible Debt figures came in at $400.0 million (Q1 2013), $400.0 million (Q4 2012), and $400.0 million (Q3 2012), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.01 Bn | 628.25 Bn | 17.26 Bn |
| 2 | AbbVie | 468.55 Bn | 462.03 Bn | 12.70 Bn |
| 3 | Merck | 365.49 Bn | 358.40 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.39 Bn | 265.10 Bn | 11.24 Bn |
| 5 | Astrazeneca | 253.18 Bn | 247.96 Bn | 12.86 Bn |
| 6 | Amgen | 219.53 Bn | 205.54 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 187.85 Bn | 184.59 Bn | 6.22 Bn |
| 8 | Pfizer | 160.56 Bn | 149.16 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 130.81 Bn | 122.96 Bn | 2.84 Bn |
| 10 | Bristol Myers Squibb | 124.95 Bn | 113.89 Bn | 9.25 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2013 | 400.00 Mn |
| Dec 31, 2012 | 400.00 Mn |
| Sep 30, 2012 | 400.00 Mn |
| Jun 30, 2012 | 400.00 Mn |
| Mar 31, 2012 | 400.00 Mn |
| Dec 31, 2011 | 400.00 Mn |
| Sep 30, 2011 | 400.00 Mn |
| Mar 31, 2011 | 400.00 Mn |
| Dec 31, 2010 | 400.00 Mn |
| Sep 30, 2010 | 400.00 Mn |
| Mar 31, 2010 | 32.10 Mn |
API Access
Vertex Pharmaceuticals Convertible Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=convertible-debt&ticker=VRTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "convertible-debt", "ticker": "VRTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=convertible-debt&ticker=VRTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();